Wei Ma
- Cancer Research top 10%
- MicroRNA in disease regulation 13
- Cancer-related molecular mechanisms research 8
-
- Circular RNAs in diseases 8
- RNA modifications and cancer 5
- Biochemistry top 10%
- Obstetrics and Gynecology top 10%
-
- Spinal Dysraphism and Malformations 10
-
- Bone Tissue Engineering Materials 6
-
- Dental Implant Techniques and Outcomes 5
-
- Congenital Anomalies and Fetal Surgery 5
Wei Ma
79 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 119
- Cancer Research 280
- Molecular Biology 585
- Biochemistry 43
- Obstetrics and Gynecology 45
- Complementary and alternative medicine 45
Countries citing papers authored by Wei Ma
This map shows the geographic impact of Wei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Ma more than expected).
Fields of papers citing papers by Wei Ma
This network shows the impact of papers produced by Wei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Ma. The network helps show where Wei Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 12 | |
| 3 | 2024 | 14 | |
| 4 | 2023 | 8 | |
| 5 | 2023 | 10 | |
| 6 | 2022 | 11 | |
| 7 | 2022 | 2 | |
| 8 | 2021 | 21 | |
| 9 | 2021 | 31 | |
| 10 | 2021 | 8 | |
| 11 | 2020 | 18 | |
| 12 | 2020 | 16 | |
| 13 | 2020 | 2 | |
| 14 | 2019 | 12 | |
| 15 | 2019 | 16 | |
| 16 | 2019 | 16 | |
| 17 | 2019 | 4 | |
| 18 | 2013 | 13 | |
| 19 | 2012 | 8 | |
| 20 | 2008 | 12 |
About Wei Ma
Wei Ma is a scholar working on Cancer Research, Genetics and Oral Surgery, having authored 80 papers that have together received 1.2k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (13 papers), Spinal Dysraphism and Malformations (10 papers), Cancer-related molecular mechanisms research (8 papers), Circular RNAs in diseases (8 papers), Bone Tissue Engineering Materials (6 papers), Dental Implant Techniques and Outcomes (5 papers), Congenital Anomalies and Fetal Surgery (5 papers) and RNA modifications and cancer (5 papers). The work is most often cited by research in Cancer Research (280 citations), Molecular Biology (585 citations) and Biochemistry (43 citations). Wei Ma has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhengwei Yuan, Xiaowei Wei, Hui Gu, Dan Liu, Kai‐Jin Wang, Guoqing Yan, Ning Li, Yong‐Xian Cheng, Wenting Luo and Weilin Wang. Their work appears in journals such as Frontiers in Cell and Developmental Biology, Journal of Biomedical Materials Research Part B Applied Biomaterials, Cell Death and Disease, Scientific Reports and Annals of the New York Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.